Transglutaminases (TG) are externalized from cells via an unknown unconventional secretory pathway. We show for the first time that purinergic signaling regulates active secretion of TG2, an enzyme with a pivotal role in stabilizing extracellular matrices and modulating cell-matrix interactions in tissue repair. Extracellular ATP promotes TG2 secretion by macrophages, and this can be blocked by a purinergic receptor P2X7 (P2X7R)-selective antagonist. Introduction of functional P2X7R into HEK293 cells is sufficient to confer rapid, regulated TG2 export. By employing pharmacological agents, TG2 release could be separated from P2X7R-mediated microvesicle shedding. Neither, Ca 2+ signaling alone nor membrane depolarization triggered TG2 secretion which occurred only upon receptor membrane pore formation and without pannexin channel involvement. A gain-of-function mutation in P2X7R associated with autoimmune disease caused enhanced TG2 externalization from cells, and this correlated with increased pore activity.
Introduction
Unconventional export of cytoplasmic proteins, i.e. the processes by which proteins that do not follow the classical ER/Golgi secretory pathway are secreted by cells, is being studied extensively as many molecules that fall into this category constitute potent biological signals with key roles in developmental or inflammatory processes. Such proteins lack posttranslational modifications that occur during ER/Golgi protein maturation but may be subject to N-terminal processing and acetylation or acylation (Muesch et al., 1990; Stegmayer et al., 2005) . Several fundamentally different mechanisms appear to support unconventional protein secretion including self-sustained or transporter-facilitated direct membrane translocation at the plasma membrane, or release in specialized vesicles, the biogenesis of which is distinct from coat protein complex II-coated vesicles (Nickel and Rabouille, 2009; Rabouille et al., 2012) . Neither export through the compartment for unconventional protein secretion/multivesicular body pathway nor direct microvesicle (MV) shedding at the plasma membrane requires membrane translocation of the cargo, and release is thought to occur by vesicle lysis in the extracellular environment.
Transglutaminases (TG) are a family of structurally similar enzymes that posttranslationally modify proteins through transamidation, deamidation or esterification of glutaminyl residues (Aeschlimann and Thomazy, 2000) . Several of these enzymes have well established functions in stabilizing extracellular protein assemblies, including TG2 (wound healing), TG4 (semen coagulation) and factor XIII (blood coagulation) (Aeschlimann and Paulsson, 1994; Lorand and Graham, 2003) . More recently, TG3 and TG6 have been implicated in extracelluar functions (Zone et al., 2011; Thomas et al., 2013) . Despite it being 20 years since we first postulated export of TGs through an unconventional secretory pathway (Aeschlimann and Paulsson, 1994) , the underlying process remains elusive. This has gained much attention recently as while matrix stabilization by TG2 is required for an effective tissue repair response, aberrant TG2 action has a central role in pathogenesis of inflammatory diseases and autoimmunity, most noteably celiac disease (Aeschlimann and Thomazy, 2000; Iismaa et al., 2009) . Externalization from cells appears synthesis level and extracellular activity, and the fact that export appears to be cell type or differentiation stage specific as exemplified in endochondral bone formation (Aeschlimann et al., 1995) . Such sudden, context-dependent externalization of TG2 indicated that its export is regulated by an unidentified signaling event.
One emerging pathway for non-classically secreted proteins including interleukin (IL)-1 involves P2X7R activation, leading to formation of an inflammasome in a NALP3-dependent manner (Dubyak, 2012; Strowig et al., 2012) . Inflammasome assembly drives caspase-1 autoprocessing, maturation of IL-1 by caspase-1 cleavage and ultimately IL-1 release (Mariathasan et al., 2006) . Activated macrophages derived from P2X7R-/-mice are unable to secrete the mature form of IL-1 family cytokines including IL-1β and IL-18 (Solle et al., 2001; Pelegrin et al., 2008) and hence, these animals show reduced severity in models of acute inflammatory joint or lung disease (Labasi et al., 2002; Lucatelli et al., 2011; Bartlett et al., 2014) .
P2X7R is a member of the P2X family of nucleotide gated ion channels that is activated by high concentrations of extracellular ATP. Besides K + efflux that triggers inflammasome assembly, the ion channel also supports Ca 2+ and Na + influx, leading to membrane depolarization and activation of intracellular signaling cascades (Coddou et al., 2011; Bartlett et al., 2014) . The P2X4R crystal structure confirmed that assembly of 3 subunits, each harboring two transmembrane domains, forms the functional P2X receptor (Kawate et al., 2009) . The large extracellular domain has ATP and metal ion binding sites that regulate receptor activation state. Channel opening is associated with conformational changes that reposition the transmembrane segments whereby different states of dilation may be adopted (Hattori and Gouaux, 2012; Jiang et al., 2013) . The feature that distinguishes P2X7R from the other P2X family members is a long C-terminal tail (Suprenant et al., 1996; Rassendren et al., 1997) which has been implicated in the process of "membrane pore" formation that enables plasma membrane permeability to larger organic cations (Virginio et al., 1999; Browne et al., 2013) .
High extracellular ATP is a consequence of cell damage, and enforced by ATP release from activated innate immune cells. This acts as a danger signal amplification system that spreads the alarm within the local milieu. However, ATP is not only released upon tissue/cell injury or stress, but can also be secreted through membrane channels or secretory vesicles (Garcia and Knight,
Results

Macrophages secrete TG2 in a P2X7R-dependent manner
The THP-1 monocyte/macrophage cell model was chosen to investigate TG2 export as these cells have been reported to be competent in P2X7R-mediated IL-1β secretion (Mackenzie et al., 2001 ).
We confirmed initially that activation of inflammasome formation by priming cells with lipopolysaccharide (LPS) for Toll-like receptor (TLR) signaling and subsequent stimulation with ATP induces IL-1β secretion into the cell supernatant as determined by capture ELISA (Fig. S1A ).
TG2 is expressed in differentiated macrophages but not in monocyte precursors (Mehta and LopezBerestein, 1986) . Therefore, THP-1 cells were treated with the phorbol ester TPA to induce differentiation ( Fig. S1B) , and TG2 upregulation was confirmed by Western blotting of cell lysates (Fig. 1A) . We then used the ATP analogue BzATP for P2X7R activation as it shows a high degree of selectivity for P2X7R and does not activate P2Y family ATP-sensing receptors (Coddou et al., 2011) . Differentiated cells were BzATP stimulated for 10min, and culture supernatants were collected at the end of agonist treatment (pulse) and after a further 30min in the absence of agonist (chase) to capture immediate and potentially delayed TG2 secretion. BzATP stimulation induced a substantial increase in TG2 secretion as determined by Western blotting of cell-free supernatant (Fig. 1B) . TG2 export was blocked by P2X7R antagonist A740003 (Fig. 1B ) that inhibits IL-1β secretion in differentiated monocytes (Honore et al., 2006) . To substantiate this finding, we analysed TG2 secretion in response to P2X7R activation in primary human M1 macrophages.
BzATP triggered rapid TG2 secretion, contributing to soluble (Fig. 1C ) and cell surface associated enzyme ( Fig. S1C ) whereby the soluble enzyme was undergoing processing generating a ~66kDa species. Processing did not involve inflammasome-associated caspase-1 nor cell surface MT1-MMP cleavage (Belkin et al., 2001) as it occurred in the presence of N-acetyl-YVAD-chloromethyl ketone (Ac-YVAD-CMK) or EDTA, respectively ( Fig. 1D & S1C) . Collectively, these data show that P2X7R regulates not only 1L-1 but also TG2 secretion in macrophages.
Expression of P2X7R confers agonist-inducible, rapid TG2 secretion to HEK293 cells
To investigate whether P2X7R alone was sufficient or other inflammasome pathway components are required for TG2 export, we established HEK293 cells stably expressing wildtype or tagged human P2X7R. This cell model was selected as it lacks endogenous expression of P2X receptor family members (Mackenzie et al., 2005) and secretes mature IL-1 in response to agonist when cotransfected with P2X7R and pro-caspase-1 (Gudipaty et al., 2003) . P2X7R expression was confirmed by Western blotting of cell extracts, whereby for tagged P2X7R a single band reactive with antibodies to P2X7R and the V5-tag was detected (Fig. S2A ). Immunocytochemistry Journal of Cell Science • Advance article confirmed membrane localization of the receptor in P2X7R cells and its absence in parental cells (Fig. S2B) . In order to assess P2X7R functionality, changes in intracellular free Ca 2+ concentration in response to BzATP were investigated using Fluo-4-AM. Only P2X7R cells but not parental cells responded to this agonist (Fig. S2C) . A dose-response analysis for BzATP stimulation of P2X7R cells using Ca 2+ signaling as a readout derived an apparent KD of ~75M (Fig. S2D ). This is in line with literature data ranging from 40-100M depending on extracellular Ca 2+ concentration (Rassendren et al., 1997) . Therefore, stimulation with 100M BzATP produced a P2X7R specific and in terms of ligand occupancy, relevant response for further investigation of downstream events.
We then investigated whether P2X7R activation induces TG2 secretion. TG2 transfected P2X7R cells were treated with agonist for 5, 10 or 30min, followed by a 30min chase period after agonist wash out. Supernatants of both fractions were analysed for TG2 by Western blotting.
Within 10min of BzATP application, pulse fractions revealed substantial TG2 secretion in agonist treated but not vehicle treated cells ( Fig. 2A) . No TG2 export was seen after 5min indicating that kinetics were considerably slower than Ca 2+ signaling. Interestingly, elevated TG2 levels in the chase fraction were observed in cells that were exposed to BzATP for 5min ( Fig. 2A ) or even 1min
(not shown), indicating that P2X7R activation and not subsequent events occurring upon prolonged agonist exposure triggers TG2 export. As TG2 levels in the chase fraction were agonist exposure time independent ( Fig. 2A ) it appears that once initiated, the TG2 export mechanism is active over an extended time period and leads to gradual extracellular TG2 accumulation at a constant rate.
Note, the amount of secreted TG2 is small compared to the total and hence, export does not deplete cellular TG2 over time period investigated (Fig. 2D , cell lysate). To further demonstrate that this cell response required P2X7R activity, we employed the competitive P2X7R inhibitor A740003. At 5M, it completely blocks a rise in [Ca 2+ ]i in response to BzATP (Fig. 2B , top panel), and this is reversible upon inhibitor wash out (Fig. 2B , bottom panel). BzATP stimulation of cells in the presence of this inhibitor was unable to trigger TG2 secretion (Fig. 2C) , demonstrating that active secretion of TG2 is a P2X7R regulated process.
P2X7R-mediated TG2 export is not linked to loss of cell membrane integrity or apoptosis
Shedding of membrane-bound particles containing TG2 together with the lipid raft protein flotillin-2 was reported (Antonyak et al., 2011) . Hence, we investigated whether P2X7R-mediated TG2 secretion correlated with flotillin-2 release. Western blot analysis of cell lysates confirmed that flotillin-2 and TG2 were expressed at comparable levels in P2X7R and parental cells (Fig. 2D , cell lysate). Only P2X7R cells responded to BzATP stimulation with release of flotillin-2 into the cell supernatant, indicating P2X7R-dependent vesicle shedding (Fig. 2D, medium) . Similar to TG2, Journal of Cell Science • Advance article flotillin-2 was present in the pulse fraction and accumulated in the chase fraction, potentially indicating co-release. To further analyse secreted material and exclude protein release through passive cell lysis we investigated externalization of the cytosolic proteins IB, -tubulin, as well as of HMGB-1 which is secreted non-classically via the exosome pathway (Lu et al., 2012) . We were unable to detect any of these proteins in the cell supernatant after P2X7R activation ( Fig. 2E & not shown) . However, given that prolonged stimulation of P2X7R can lead to cell death (Mackenzie et al., 2005) , and this critically affects the conclusions, we designed experiments to more selectively investigate loss of membrane integrity and apoptosis, respectively.
Firstly, release of cytosolic lactate dehydrogenase (LDH) was quantified after stimulation of either P2X7R or parental cells with BzATP for 10min. No P2X7R induced release of LDH was seen (Fig.   S3A ). Secondly, BzATP treated P2X7R cells were chased for various times up to 22h and assessed for caspase-3 activation by Western blotting. Activated caspase-3 could not be detected at any time ( Fig. S3B ) whereas within 6h of TNF stimulation caspase-3 cleavage was evident as reported (Arlt et al., 2003) . These data show that TG2 externalization is not related to cell damage or death but is a selective process, possibly linked to P2X7R-dependent membrane changes. This is consistent with activation of P2X7R triggering rapid alterations in membrane topology without causing cell death that completely reverse as [Ca 2+ ]i falls unless receptor stimulation is sustained for long time periods (Mackenzie et al., 2005) .
TG2 localizes to membrane subdomains upon cell stimulation with P2X7R agonist
In P2X7R expressing cells, the prolonged increase in [Ca 2+ ]i upon BzATP application was followed within 30s by extensive cell blebbing as visualized by real-time microscopy ( Fig. 3A , arrows). The term 'blebbing' is used here to describe formation of plasma membrane projections due to Rhodependent actin reorganization that follow P2X7R activation (MacKenzie et al., 2001; Pfeiffer et al., 2004) . This response is P2X specific. Stimulation of the parental cells that express P2Y
receptors with ATP induced smaller, transient oscillations in [Ca 2+ ]i but no apparent morphological changes ( Fig. 3A) . This led us to speculate that TG2 externalization may be linked to membrane bleb formation, and we used GFP-tagged TG2 to monitor its redistribution in live cells. We confirmed that P2X7R activation triggered externalization of tagged TG2 similar to wild-type TG2
( Fig. 3B ). Analysis by confocal microscopy revealed a clear ubiquitous cytoplasmic distribution for TG2-GFP (Fig. 3C ). Upon P2X7R activation, TG2-GFP was rapidly translocating into membrane blebs, and freely relocalized to sites where new membrane protrusions formed (Fig. 3C , arrow).
However, despite abundant bleb formation, careful reconstruction from image sequences revealed that these large membrane protrusions remained continuous with the plasma membrane and were eventually retracted by cells. We obtained similar results for N-and C-terminally tagged TG2 Journal of Cell Science • Advance article indicating that the position of the tag did not substantially alter protein localization. Although unable to directly visualize TG2 release, a noticeable reduction in fluorescence upon P2X7R activation indicated that the intracellular pool of TG2 was rapidly diminishing consistent with its relocation into the medium (Fig. 3B ).
P2X7R agonist-induced TG2 secretion is independent of MV shedding
As small vesicles may be released by cells that are beyond the resolution of conventional confocal microscopy, we used light scattering combined with particle tracking to further analyse cell free supernatants for nanoparticles. A robust increase in particle shedding by P2X7R cells upon BzATP treatment was observed during stimulation and in the subsequent chase period ( localizes in MV, freshly harvested conditioned medium was subjected to differential centrifugation and resulting pellets and supernatant were analysed by Western blotting (Fig. 4C ). TG2 mainly localized to the 100,000xg supernatant fraction containing soluble proteins (S5), with some TG2
found in very large aggregates or associated with organelles (P2) but not in the MV fraction (P4).
To substantiate this, MV were separated using a sucrose density gradient (Fig. 4D ). Again, TG2
was predominantly in the soluble protein fraction. These data suggest that while P2X7R activation induces abundant MV release by cells, secreted TG2 is not apparently MV-associated but present in free form.
Extracellular Ca 2+ regulates TG2 externalization but its secretion is independent of catalytic enzyme functions
TG2 secretion was effectively stimulated by P2X7R activation in media that contain 0.9mM Ca 2+ , which is similar to the free ionized extracellular Ca 2+ concentration estimated at 1.1-1.3mM (Riccardi and Kemp, 2012 ), but surprisingly not in media containing high Ca 2+ ( Fig. 1D & 5A ).
BzATP treatment of cells in the absence of Ca 2+ lead to enhanced TG2 secretion during stimulation only ( Fig. 5A ), indicating that TG2 export was faster but not sustained. In contrast, flotillin-2 release occurring at 0.9mM Ca 2+ was greatly reduced when cells were stimulated with agonist at either 0 or 2.2mM Ca 2+ (Fig. 5A ). This shows that TG2 and flotillin-2 secretion is differentially affected by [Ca 2+ ]ex and hence, that the underlying mechanisms are distinct. As MV shedding is a Ca 2+ -dependent process, TG2 release in Ca 2+ -free medium supports a vesicle-independent mode of release in line with previous data (Fig. 4) .
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To exclude Ca 2+ -dependent loss of externalized TG2 due to cell surface retention through interaction with substrates or autocatalytic crosslinking, we compared secretion of wild-type TG2
with crosslinking incompetent TG2 C 277 S (Stephens et al., 2004 ]ex is not due to TG2 activity but may reflect differences in P2X7R activation state. This is further supported by high [Ca 2+ ]ex affecting flotillin-2 release as well (Fig 5A) . Besides cation transport, activation of P2X7R can lead to "membrane pore" formation which manifests as apparent permeability of the plasma membrane to cationic molecules such as YO-PRO1 (Virginio et al., 1999; Pelegrín, 2011; Browne et al., 2013) .
Measurement of YO-PRO1 uptake confirmed that P2X7R cells but not parental cells form membrane pores upon BzATP treatment (Fig. 5C) , and that the dye uptake rate is inversely correlated to [Ca 2+ ]ex (Fig. 5D ). Ca 2+ -nucleotide interactions could potentially limit the effective agonist concentration. However, the observed BzATP dose response is not consistent with this explanation (Fig. S3C) . Therefore, Ca 2+ likely acts in our experiments as an allosteric regulator of P2X7R, either directly or indirectly inhibiting receptor activation as previously suggested (Yan et al., 2011) . Taken together, this suggests that high [Ca 2+ ]ex is an important negative regulator of TG2 secretion, whereby Ca 2+ ions appear to regulate P2X7R activation rather than influencing TG2 activity during export.
TG2 export is linked to P2X7R-mediated membrane pore formation
To assess the contribution of the initial ion flux on TG2 secretion, calmidazolium was employed. It is an inhibitor with broad selectivity for voltage gated fast acting Na + /K + and L-type Ca 2+ -channels that also inhibits the initial ATP-evoked ion flux through P2X7R without affecting the downstream membrane pore formation (Virginio et al., 1997) . Calmidazolium has an extracellular mode of action on P2X7R. BzATP induced TG2 export in P2X7R cells was unaffected by the presence of calmidazolium but flotillin-2 secretion was blocked (Fig. 6A ). The inhibitor had no effect on pore formation activity of P2X7R (Fig. 6B ) but substantially reduced the rise in [Ca 2+ ]i mediated by P2X7R activation (Fig. 6C ). This indicates that TG2 secretion is linked to P2X7R-dependent pore formation but not the initial ion flux and associated membrane depolarization.
Given that TG2 secretion was induced by P2X7R activation in Ca 2+ -free medium but the kinetics of export were altered (Fig. 5A ), we investigated whether Ca 2+ release from intracellular stores plays a role. P2X7R cells were pre-loaded with Ca 2+ chelator BAPTA-AM to buffer free cytosolic Ca 2+ prior to BzATP stimulation in Ca 2+ -free medium. This reduced TG2 release to near baseline levels (Fig. S3D) , confirming that Ca 2+ signaling has a role in TG2 export as previously Journal of Cell Science • Advance article suggested (Zemskov et al., 2011) . Conversely, cyclopiazonic acid (CPA) was applied to inhibit the SERCA Ca 2+ transporter to trigger a rise in [Ca 2+ ]i in the absence of P2X7R activation. CPA addition alone was unable to induce TG2 secretion (Fig. S3D) , despite inducing peak [Ca 2+ ]i of the same magnitude as P2X7R activation when used at 20M (Fig. S3E) . This indicates that a rise in [Ca 2+ ]i by itself is not sufficient to induce TG2 export.
TG2 secretion is pannexin independent but enhanced by activating mutations in P2X7R
P2X7R-mediated membrane pore formation has been proposed to relate to P2X7R channel dilation upon saturation of ATP binding sites, possibly combined with acquisition of additional subunits We therefore sought to clarify whether the C-terminally truncated P2X7R splice variant B that lacks pore forming ability (Adinolfi et al., 2010) supports TG2 secretion. However, expression of this variant after site-specific stable integration or transient transfection was very low as determined by
Western blotting of cell lysates (Fig. 7B) , and we were unable to confirm cell surface localization with P2X7R extracellular domain antibodies. Nevertheless, we attempted to confirm agonistmediated membrane depolarization using the sensitive voltage sensing FRET probes CC2-DMPE and DiSBAC2 (Wolff et al., 2003 A mutation in mouse P2X7R renders it deficient in pore forming activity (Sorge et al., 2012) . As the affected sequence motif in the P2X7R C-terminal domain is conserved in human, we have generated cells expressing human P2X7R with an analogous mutation, P 451 L (Fig. 7B,C) .
However, these cells formed membrane pores in response to BzATP as revealed by YO-PRO1 uptake (Fig. 7D ). This led us to investigate the gain of function P2X7R variant, A 348 T, that confers increased risk for autoimmune disease in man (Stokes et al., 2010) to substantiate a link between pore formation and TG2 secretion. Cells expressing P2X7R A 348 T (Fig. 7B,C) had a substantially increased propensity to form membrane pores as evidenced by enhanced peak pore activity ( Fig.   7D ) and by pore formation at very low BzATP concentrations (Fig. 7E ). This enhanced pore activity was reflected in a corresponding increase in TG2 export (Fig. 7F,G) . Interestingly, we also observed BzATP-induced secretion of thioredoxin-1 (Fig. 7H) , an enzyme that can re-activate Journal of Cell Science • Advance article oxidatively inactivated TG2. This not only indicates that membrane pore activity controls the rate of TG2 export but that it leads to co-secretion of TG2 with thioredoxin-1 (Fig. 8) .
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Discussion
We identify P2X7R as the central regulator of the pathway that enables active export of TG2 and its co-activator, thioredoxin-1. The action of both of these enzymes has been linked to specific immune responses (Ismaa et al., 2009; Jaeger et al., 2013) , and this may therefore constitute a pathway for export of proteins relevant to innate immunity. Besides having roles in re-instating tissue integrity following injury or associated with infection control, TGs including TG2 have been implicated in immune regulation (Toth et al., 2009; Loof et al., 2011) . Here, we show that in monocytes/macrophages, purinergic signaling triggered rapid TG2 export in the absence of TLR engagement, and this response was P2X7R dependent but did not require caspase-1 activity.
Likewise, introduction of P2X7R in HEK293 cells devoid of other inflammasome components (Lu et al., 2012) instated agonist-regulated rapid TG2 export. Taken together, the data demonstrate that P2X7R signaling alone is sufficient to trigger TG2 export, and involvement of an inflammasomeindependent mechanism of export is further supported by the fact that externalized TG2 was not vesicle-associated or co-secreted with exosome-associated HMGB-1.
A redox sensitive Cys switch promotes oxidative inactivation of TG2 (Stamnaes et al., 2010) , a mechanism that is thought to contribute to rapid enzyme inactivation in the extracellular where it activates -defensin-1 (Jaeger et al., 2013). Interestingly, thioredoxin-1 is also an unconventionally secreted protein (Rubartelli et al., 1992) , and our results show that it is in fact cosecreted with TG2. We speculate that thioredoxin-1 may not primarily act on pre-existing extracellular TG2 but may have a role as a chaperone during active TG2 export, enabling conversion of TG2 into its active conformation. Such a mechanism could explain why in celiac disease active TG2 accumulates in the intestinal mucosa (Korponay-Szabo et al., 2004) .
Purinergic signaling fulfills the pre-requisites for a unifying pathway regulating TG export
As TG2, and also other TGs, can be externalized by a range of cells including myeloid, Crucially, in our HEK293 model TG2 is not retained at the cell surface or internalized, unless an appropriate cell surface receptor is introduced (Fig. S4) . Hence, TG2 export can be directly assessed by quantification in the cell supernatant. Thus, our system is overcoming intrinsic difficulties that hampered progress in the analysis of TG2 export previously, including quantification of cell surface associated TG2 without disrupting cell integrity or endocytic TG2 uptake and retrograde transport. This together with modulation of the different P2X7R activities with small molecules or by mutagenesis provided strong evidence for a direct link between P2X7R signaling and TG2 export. Our data is not contradictory to passive TG2 release as a consequence of a substantial insult including mechanical damage (Upchurch et al., 1987) or TLR-engagement (Siegel et al., 2008) , or to vesicle-associated TG2 release under circumstances such as serum starvation-associated cell stress (Antonyak et al., 2011) . Rather, it suggests that purinergic signaling links controlled TG2 export to specific extracellular functions. Furthermore, given that MVassociated TG2 co-localized with fibronectin (Antonyak et al., 2011) an extracellular enzyme localization is implied. Therefore, it is possible that TG2 preferentially binds to plasma membrane subdomains where specific types of MV form (pericellular matrix reorganization) explaining the apparent association but that this occurs subsequent to membrane translocation.
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Different activities of TG2 as well as sequence motifs for interaction with proteins and phospholipids were implicated in the export process (Balklava et al., 2002; Scarpellini et al., 2009; Chou et al., 2011; Zemskov et al., 2011) . Our data show that transamidation activity is dispensable for export and that tagging TG2 with GFP does not prevent export, thereby excluding a terminal targeting signal. Blocking TG2 interaction with classically secreted proteins such as fibronectin, syndecans and integrins may alter extracellular localization or endocytic uptake and trafficking of TG2 (Antonyak et al., 2011; Chou et al., 2011; Zemskov et al., 2011) but cannot explain how the implied membrane translocation occurs.
Mechanistically, TG2 export is linked to the secondary permeability pathway
Several lines of evidence show that TG2 export is linked to the "membrane pore" activity associated with P2X7R activation (Fig. 8) ]i rise alone, nor abrogated by pharmacological suppression of P2X7R ion channel function without affecting membrane pore formation. In contrast, introducing a mutation in P2X7R that enhanced pore activity resulted in accelerated TG2 export.
P2X7R is the only P2X receptor where membrane pore formation is consistently observed and this activity is therefore a defining feature of it. While mechanistically not fully understood, it requires the extended unique C-terminal intracellular tail (Smart et al., 2003; Sun et al., 2013) .
Recent data suggest that large cations can pass through the P2X7R channel itself, and that blocking the channel prevents dye uptake by cells (Browne et al., 2013) . However, a larger channel diameter than expected from available structural data (Hattori and Gouaux, 2012) would be required to adequately explain permeation of some molecules, and a more substantial conformational change than predicted from existing structural data is indeed supported by a recent study (Allsopp and Evans, 2015) . Interestingly, P2X7R also couples to effectors implicated in dye permeability and a sustained [Ca 2+ ]i elevation by itself was shown to trigger membrane pore opening (Bartlett et al., 2014) . In our HEK293 model, calmidazolium attenuated Ca 2+ influx while membrane pore activity was unaffected suggesting that distinct permeation pathways are involved. Pannexin-1 is not involved as shown with inhibitors, consistent with data of others (Sun et al., 2013) . Physiologically, the secondary permeability pathway may have a role in release of secondary messengers, e.g.
glutamate release in P2X7R expressing HEK293 cells was reported (Cervetto et al., 2013) . Given Journal of Cell Science • Advance article the delay between P2X7R-dependent Ca 2+ signaling and detection of changes in extracellular TG2, we cannot exclude a role of a secondary messenger system. However, it is conceivable that this pathway constitutes a pore through which proteins can be trafficked via co-translocational unfolding (Rodriguez-Larrea and Bayley, 2014).
TG2 activation is biological context-dependent
Given its requirement for high extracellular ATP concentration, P2X7R will primarily be activated 
Implications for TG2-mediated disease processes
P2X7R is highly polymorphic, and it has become increasingly clear that some amino acid substitutions predispose to disease (Bartlett et al., 2014) . We have shown here that a polymorphism in the second transmembrane domain that is associated with autoimmune disease (Stokes et al., 2010) facilitates membrane pore formation leading to enhanced TG2 secretion. This opens the possibility that the threshold for activation of TG2 export differs between individuals depending on their P2RX7 genotype, and this may constitute a risk factor for diseases where TG2 mediated reactions cause pathology. This extends to animal models of disease. Notably, in contrast to mouse strain 129, the C57BL/6 background widely used in genetic studies carries P2X7R P 451 L which lacks the capacity to form membrane pores (Sorge et al., 2012) . Different mouse lines may therefore differ with regards to the capacity for active TG2 export.
In conclusion, we have demonstrated that TG2 export is regulated by purinergic signaling, and that P2X7R plays a central role in this process. Our findings provide an explanation for the link between high levels of extracellular TG2 activity and inflammatory responses, and thereby identify Journal of Cell Science • Advance article a new avenue to limit TG2 activity therapeutically in conditions where enzyme function directly drives pathogenic processes including fibrotic disease and gluten related disorders.
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Materials and methods
Cell culture
THP-1 monocytic leukemia cells were grown in suspension in RPMI1640 medium containing 10%
heat inactivated FBS, streptomycin, and penicillin. Mononuclear cells were isolated from heparinised human blood on Ficoll-Plaque PREMIUM (GE Healthcare), washed in PBS, and cultured for 7 days as THP-1 cells but with addition of 20ng/ml human GM-CSF (Preprotech) to derive M1 macrophages (with informed consent of donors and approval of the Research Ethics
Committees: REC10/MRE09/28). HEK293 flp-in cells (Invitrogen) were cultured in DMEM containing 10% FBS, above antibiotics and 100g/ml zeocin (Invitrogen). Experiments were conducted without antibiotics.
Generation of stably transfected cell lines
P2X7R was amplified by PCR from image clone (ID:4298811) using primers specified in Table S1 to generate wild-type, truncated and V5-tagged coding sequences, which were cloned into pcDNA5/V5-His/FRT vector (Invitrogen). Constructs for P2X7R mutants were generated by site directed mutagenesis using oligonucleotides given in Table S1 . The coding sequence of all constructs was verified by sequencing. Cell lines were generated by co-transfection of P2X7R and recombinase (pOG44, Invitrogen) expression vectors into HEK293 flp-in cells using FuGENE 6 (Promega), followed by selection of stable transfectants with hygromycin B (100g/ml).
THP-1 cell differentiation and activation
Cells were differentiated with 0.5g/ml TPA, and for IL-1 upregulation, treated with 100ng/ml LPS for 24h. For activation, cells (1x10 6 /well) were suspended in PSS (10mM Hepes/NaOH, pH 7.4, 147mM NaCl, 2mM KCl, 1mM MgCl2, indicated CaCl2 concentration, and 12mM glucose) and ATP stimulated. Medium was carefully collected and rendered cell-free by centrifugation
(1,500xg, 10min). Cells were extracted on ice in 20mM Hepes/NaOH, pH 7.4, 150mM NaCl, 1mM
EGTA, 1% Triton-X100, 0.25% deoxycholate, 10% glycerol, 1mM PMSF and 1mM Nethylmaleimide, and the extract cleared by centrifugation (15,000xg, 10min, 4˚C) . IL-1 concentration in conditioned media (100l) was determined by capture ELISA (Ready-SET-Go Set, eBioscience).
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Immunocytochemistry
Cells grown on poly-L-lysine coated coverslips were fixed with 2% paraformaldehyde/PBS for 10min, and permeabilized in 0.1% Triton-X100/PBS. After blocking of non-specific binding with 1% BSA/PBS, P2X7R was detected with 2g/ml anti-P2X7R antibodies (sc-25698, Santa-Cruz) and Alexa Fluor 488-conjugated secondary antibodies. Coverslips were mounted using Vectashield containing DAPI.
[Ca 2+ ]i measurements in individual cells
Fluo - 
Analysis of TG2 externalization
Differentiated THP-1 cells (1x10 6 /well) and primary macrophages (1x10 5 /well, 24-well plates) were stimulated with P2X7R agonists in OptiMEM. HEK293 P2X7R or parental cells (1.5x10 5 /well, 24-well plates) were transfected with 0.5g expression construct for wild-type TG2 or TG2 C 277 S (Stephens et al., 2004) , or GFP-tagged TG2 (Table S2) NEB) . Antibody labeling was performed as described (Aeschlimann et al., 1993 ) using monoclonal CUB7402 to TG2 (0.2g/ml), TUB2.1 to -tubulin (2.6g/ml), to flotillin-2 (0.5g/ml; 610383, BD-Biosciences), to HMGB-1 (0.73g/ml; ab184203, Abcam), to V5-tag (20ng/ml) or polyclonal anti-IB (1g/ml; sc-371, Santa-Cruz), anti-caspase-3 (40ng/ml; 9662, Cell-Signaling), anti-P2X7R C-terminus (1g/ml) or anti-P2X7R extracellular domain (1.7g/ml; APR-008, Alomone Labs) antibodies. Anti-thioredoxin-1 antibodies (1:200; FL105, Santa-Cruz)
were used with 5% casein as blocking agent. Bound antibodies were detected with HRP-conjugated secondary antibodies and Amersham ECL TM Plus/Prime. TG2 band intensity was quantified by densitometry using Image Lab 5.1 software (Bio-Rad).
Analysis of cell damage and apoptosis
To assess cell integrity, LDH release was measured using CytoTox-ONE TM HMI Assay (Promega).
Cells (1.2x10 5 /well, 24-well plate) were BzATP-treated in 300l OptiMEM for 10min (n=4), and cell-free conditioned media (100l) analyzed for LDH. For estimation of total LDH, a replicate well set was subjected to cell lysis.
To assess whether treatment induced cell death, P2X7R cells were BzATP stimulated and chased as described, and where indicated subsequently cultured in serum containing DMEM for up to 22h. Cell extracts and particulate material recovered from conditioned media were analysed for caspase-3 by immunoblotting.
Localization of GFP-tagged TG2 using confocal microscopy P2X7R cells on poly-L-lysine coated coverslips were transfected with constructs for expression of N-or C-terminally GFP-tagged TG2. After 24h, the coverslip was mounted for microscopy into a customized holder using silicone grease. Cells were kept in OptiMEM at 37˚C/5% CO2, and stimulated with a defined volume of agonist solution to obtain 1mM ATP or 100M BzATP while Journal of Cell Science • Advance article monitoring GFP fluorescence and acquiring real-time movies.
Detection and isolation of MV
TG2 or mock transfected P2X7R cells were stimulated with 100M BzATP or vehicle. Freshly collected conditioned media were rendered cell-free by centrifugation (1,500xg, 10min) and supernatants analysed for MV by particle tracking using the NanoSight LM12 system with a high sensitivity camera (Webber and Clayton, 2013) . Five 60s videos per sample (1-5x10 8 particles/ml) were recorded at 25.6 frames/s (gain=250), and analysed using the NTA2.3 software. Alternatively, freshly collected conditioned media were subjected to differential centrifugation at 4˚C, with 1,500xg for 10min, followed by 3,000xg for 20min, and then either 10,000xg for 30min and 100,000xg for 1h or subjected to density gradient centrifugation. Supernatant (1.0 ml) was carefully layered on Tris-buffered sucrose step gradient (0/20/60%) and centrifuged at 100,000xg for 90min.
Fractions (~1ml) constituting top layer and 20/60% interface (MV fraction) as well as pellet were collected. Proteins were precipitated with 9 volumes of ethanol at 4˚C, and analysed using immunoblotting. .
P2X7R "membrane pore" activity
Fmax was then plotted against the agonist concentration to derive a dose-response curve.
Membrane potential analysis
Voltage sensor probes, coumarin-labeled phospholipid CC2-DMPE (FRET donor) and oxonol dye 
